Pfizer Inc

Vaccine maker stocks rise as China battles worst Covid outbreak since 2020
Health

Vaccine maker stocks rise as China battles worst Covid outbreak since 2020

Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders. Moderna‘s stock jumped more than 8% to close at $150.07. In the morning, the biotech company’s stock had surged nearly 20% […]

Read More
Dr. Gottlieb says China is ‘very vulnerable’ to omicron subvariant spread despite ‘zero-Covid policy’
Health

Dr. Gottlieb says China is ‘very vulnerable’ to omicron subvariant spread despite ‘zero-Covid policy’

Low levels of natural immunity are complicating China’s efforts to limit spread during its recent surge in cases of the new Covid omicron BA.2 subvariant, Dr. Scott Gottlieb told CNBC on Monday. “China has a population that’s very vulnerable to this new variant. This is a much more contagious variant, it’s going to be harder […]

Read More
Two years into the coronavirus pandemic, Fauci hopes the world will not forget lessons from a ‘catastrophic experience’
Health

Two years into the coronavirus pandemic, Fauci hopes the world will not forget lessons from a ‘catastrophic experience’

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, arrives for a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters As the two-year anniversary of the coronavirus […]

Read More
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
Health

Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants

Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. “I think we’re going to submit to FDA a significant progress of data about the need for a fourth […]

Read More